MedTrace Logo

Botox in the Healing of Surgical Wounds of the Neck

NCT01177358 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-08-21

No results posted yet for this study

Summary

The investigators hypothesize that Botox A will reduce scarring and improve healing of surgical neck wounds.

Conditions

  • Scar

Interventions

DRUG

Botulinum Toxin Type A

A vial of Botulinum Toxin A containing 100U of Botox will be reconstituted with 2mL of normal saline for a concentration of 50U/mL. 5 units (0.1mL) of Botulinum Toxin a will be injected at midline and 1.5cm lateral to midline, bidirectionally, following a thyroidectomy or parathyroidectomy.

DRUG

Normal Saline

0.1mL of normal saline in a placebo vial containing 2mL of normal saline will be injected along three sites (midline and 1.5cm lateral from midline) following a thyroidectomy or parathyroidectomy.

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Nova Scotia Health Authority

    lead OTHER

Principal Investigators

  • Mark Taylor, FRCS · Capital District Health Authority Nova Scotia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2016-05-05
Completion
2016-05-05

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01177358 on ClinicalTrials.gov